Business

NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil

Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the ...

articleNugen Medical Devices IncJuly 1, 20245/company/nugen-medical-devices-inc/news/nugen-announces-completion-of-insujettm-training-with-sol-millenniumtm-brazil
NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil

About this update from Nugen Medical Devices Inc

[{"type":"text","content":"NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) BrazilToronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the \"Company\" or \"NuGen\") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of June 26, 2024, the commercial teams of Sol-MillenniumTM Medical Inc. (\"Sol-MTM\") in Brazil have successfully completed the sales and in-depth clinical training required for InsuJetTM's launch in the Brazilian market. This is the next step in the rollout plan for Sol-MTM as a key InsuJetTM distributor, building on NuGen's June 21, 2024, announcement of Sol-MTM purchase orders placed for customer demand in Canada and Europe.With a population of over 200 million, Brazil is a major South American market and a key growth target for NuGen. The InsuJetTM has regulatory approval for sale in Brazil and training the Sol-MTM team enables the launch into this large and important market.NuGen's CEO Ian Heynen commented \"The training of the commercial teams at Sol-MTM Brazil is another significant step forward in our global rollout plan. Sol-MTM's teams are now poised to develop the InsuJetTM in NuGen's largest addressable market in South America[1] and we expect to see purchase orders in the near future.\"About NuGen:NuGen is a leading developer of needle-free devices to administer therapeutics subcutaneously. The Company is marketing and selling its next-generation InsuJet™ needle-free injection system designed to improve the lives of millions of diabetics. InsuJet™ is approved for sale in 42 countries around the world.About Sol-MillenniumTM:Sol-MTM is one of the world's largest manufacturers of needles and syringes. It is vertically integrated with locations across the globe. Sol-MTM's innovative technology helps positive patient outcomes, saves on medication, and enhances both clinician and patient experience. With an international sales team dedicated to delivering knowledge and outstanding customer service, Sol-MTM's goal is to partner with those in healthcare, focusing on a healthier tomorrow.For further information, please visit: Websites: www.insujet.com, www.nugenmd.com and www.solm.com/insujet/Instagram: @NuGenMDTwitter: @NuGenMDLinkedIn: https://www.linkedin.com/company/nugenmd/ and www.link...

More updates from Nugen Medical Devices Inc